| Literature DB >> 29178899 |
Susanne Vahr Lauridsen1, Thordis Thomsen2,3, Gudrun Kaldan2, Line Noes Lydom4, Hanne Tønnesen5,6,7.
Abstract
BACKGROUND: Despite smoking and risky alcohol drinking being modifiable risk factors for cancer as well as postoperative complications, perioperative cessation counselling is often ignored. Little is known about how cancer patients experience smoking and alcohol interventions in relation to surgery. Therefore the aim of this study was to explore how bladder cancer patients experience a perioperative smoking and alcohol cessation intervention in relation to radical cystectomy.Entities:
Keywords: Alcohol cessation; Bladder cancer; Cancer patient; Qualitative study; Smoking cessation; Surgery
Mesh:
Year: 2017 PMID: 29178899 PMCID: PMC5702236 DOI: 10.1186/s12885-017-3792-5
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
Gold Standard Programme for smoking and alcohol cessation intervention
| Patient education programme | |
| First meeting (before admission) | |
| ◦ Level of motivation, ambivalence, pros and cons | |
| Second meeting (after 1 week) | |
| ◦ Dependence, withdrawal symptoms (experience and expectations) | |
| Third meeting (after 2 weeks) | |
| ◦ Relapse (description and management) | |
| Fourth meeting (after 3 weeks) | |
| ◦ Benefits of short and long term smoking and/or alcohol abstinence | |
| Fifth meeting (after 5 weeks) | |
| ◦ Continued smoking abstinence and/or reduced alcohol intake following intervention | |
| At each meeting | |
| Smokers: Personalized Nicotine Replacement Therapy (NRT) in accordance with patient preferences and nicotine dependency | |
| Risky drinkers: Thiamine and B-vitamins (300 mg × 7 weekly) | |
| Alcohol withdrawal prophylaxis and treatment (chlordiazepoxide 10 mg as required) | |
| Disulfiram (200 mg × 2 weekly) supervised at weekly meetings (not administrated if patients test positive on breath test) | |
| All: Hemoglobin, liver enzymes and alcohol biomarkers (blood, urine), CO and alcohol breath test, lung function test | |
| The study medication is provided for free and transportation for the weekly meetings will be reimbursed. Patients have telephone access to the research nurse |
Fig. 1Thematic network for the main finding: the smoking and alcohol cessation intervention is experienced as an integral part of bladder cancer surgery
Characteristics of the 11 participants
| Age at diagnosis, | 58 (43–77) |
| Age at smoking debut, | 15 (7–19) |
| Pack years, | 43 (26–54) |
| Fagerström Nicotine Dependency score, | 4.5 (3–6) |
| Smoking cessation intervention ( | 6 |
| Alcohol cessation intervention ( | 3 |
| Smoking and alcohol cessation intervention ( | 2 |
|
| |
| Yes | 8 |
| No | 3 |
|
| |
| Yes | 5 |
| No | 6 |
|
| |
| Yes | 4 |
| No | 7 |
|
| |
| Ileal conduit | 8 |
| Neobladder | 2 |
| Continent cutaneous diversion | 1 |